The effectiveness of nucleoside analogues in chronic hepatitis b patients unresponsive to interferon therapy: Our clinical trials for one year

Hepatitis Monthly

Volumn 10, Issue 4, 2010, Pages 289-293

  Kose, Sukran ^a   Turken, Melda ^a   Cavdar, Gulsun ^a   Akkoclu, Gulgun ^a  

^a Tepecik Research and Training Hospital   (Turkey)

Author keywords

Hepatitis b virus; Interferon therapy; Nucleoside analogues

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; NUCLEOSIDE ANALOG; TENOFOVIR;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; RELAPSE; RETROSPECTIVE STUDY; SEROCONVERSION; TREATMENT DURATION;

EID: 78649346223     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003;362(9401):2089-94.
2. Köksal I, Leblecioǧlu H. Kronik hepatitlerin tedavisinde güncel yaklaşi{dotless}mlar. 2007.
3. Sarin SK, Kumar M, Hissar S, Sharma BC. Combination of pegylated interferon and Lamivudine for patients with chronic hepatitis B who have failed treatment. Hepatobiliary Pancreat Dis Int. 2006;5(3):374-80.
4. Carreno V, Marcellin P, Hadziyannis S, et al. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology. 1999;30(1):277-82.
5. Munoz R, Castellano G, Fernandez I, et al. A pilot study of beta-interferon for treatment of patients with chronic hepatitis B who failed to respond to alpha-interferon. J Hepatol. 2002;37(5):655-9.
6. Multimer D, Naoumov NV, Honkoop P, Marinos G. Combination alfa-IFN and Lamivudinee therapy for alfa-interferon resistant chronic hepatitis B infection: Results of a pilot study. Journal of Hepatology. 1998;28(6):923-9.
7. Santantonio T, Niro GA, Sinisi E, et al. Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study. J Hepatol. 2002;36(6):799-804.
8. Schiff ER, Dienstag JL, Karayalcin S, et al. Lamivudine and 24 weeks of Lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders. J Hepatol. 2003;38(6):818-26.
9. Hartman C, Berkowitz D, Shouval D, et al. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon. Pediatr Infect Dis J. 2003;22(3):224-9.
10. Hartman C, Berkowitz D, Eshach-Adiv O, et al. Long-term Lamivudine therapy for chronic hepatitis B infection in children unresponsive to interferon. J Pediatr Gastroenterol Nutr. 2006;43(4):494-8.
11. Lebensztejn DM, Skiba E, Sobaniec-Lotowska M, Kaczmarski M. [The HBeAg/antiHBe seroconversion as a result of Lamivudine treatment in children with chronic hepatitis B unresponsive to previous interferon alpha therapy]. Pol Merkur Lekarski. 2004;16(96):557-9.
12. Akyuz F, Kaymakoglu S, Demir K, et al. Lamivudine monotherapy and Lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy. Acta Gastroenterol Belg. 2007;70(1):20-4.
13. Marcellin P, Chang TT, Lim SG, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med. 2003;348(9):808-16.
14. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med. 2003;348(9):800-7.